Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Researchers In Japan Finds Mood Stabilizing Drugs Activate Neural Stem Cells

This article was originally published in PharmAsia News

Executive Summary

A research team at the Japan National Institute of Physiologic Sciences announced May 27 that they found anti-depression mood stabilizing drugs can activate and increase neural stem cells. The group hopes the research will lead to the discovery of new treatments for brain damage caused by external injury or disease. Mood stabilizing drugs contain chemicals such as lithium and valproic acid. After three weeks, the number of brain neural stem cells of all the mice who received mood stabilizing drugs increased 1.5 over the control group. Neural stem cells increased 2.4 times in mice given lithium (Click here for more - Japanese language

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068908

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel